Navigation Links
Roger E. Laty Joins NHP as Vice President, Tax
Date:7/10/2008

NEWPORT BEACH, Calif., July 10 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced that Roger E. Laty joined NHP as its Vice President, Tax. Mr. Laty had previously been the Vice President, Taxes for Kilroy Realty Corporation since 2001. He also had over eight years experience with a "Big 4" accounting firm specializing in the taxation of real estate and Real Estate Investment Trusts. Mr. Laty is a graduate of California State University, Fullerton and is a Certified Public Accountant.

"Roger has extensive experience in the REIT sector and we are most fortunate to have him join our team," said Abdo Khoury, NHP's Chief Financial & Portfolio Officer. Nationwide Health Properties, Inc. is a real estate investment trust that invests in senior housing and other healthcare facilities. The company has investments in 562 facilities in 43 states. For more information on Nationwide Health Properties, Inc. visit our website at http://www.nhp-reit.com.

CONTACT: Abdo Khoury

Chief Financial and Portfolio Officer

(949) 718-4400


'/>"/>
SOURCE Nationwide Health Properties, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
2. Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore
3. RediClinic Adds Arkansas Blue Cross and Blue Shield Coverage in Fayetteville and Rogers
4. Kroger Pink Tag Campaign to Raise $2.5 Million for Breast Cancer Awareness in October
5. The Legendary Sir Roger Moore to be Honored at The Thalians 52nd Anniversary Gala On October 21, 2007 at the Beverly Hilton Hotel to Benefit The Thalians Mental Health Center at Cedars Sinai
6. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
7. Bryan R. Rogers Appointed President of Far West Division
8. National physician organization supports Capps-Rogers Bill at todays congressional briefing
9. Will Rogers Institute to Honor Worlds Leading Geneticist and Recent Medal of Freedom Recipient, Dr. Francis S. Collins For His Outstanding Contribution to Lung Research.
10. Ashley Forms Partnership With Roger Burgess and ProCare Rx to Carry Gotham Banner into 2008 and Beyond
11. Deli Chef Tri-Bean Salad Recalled From Some Kroger Stores

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ds rising incidence of obesity could counter recen...Dec. 2 (HealthDay News) -- The overall health of t...e decades, largely because people have quit smokin...might soon be wiped out if the rising obesity rate... current trends in both smoking and obesity contin...
(Date:12/2/2009)..., PASADENA, Calif., Dec. 2 /PRNewswire-USNewswire/...has received the Gold Seal of Approval from the Jo... stroke center. This means Huntington will join t...hroughout Los Angeles County. ,, "This is a s...portant, a wonderful benefit for Pasadena and its ...
(Date:12/2/2009)..., MONTREAL, Dec. 2 /PRNewswire/ - As part of its ... world, Wyeth, now a part of Pfizer, has pledged m...actor concentrates to the World Federation of Hemo...de to the WFH,s Humanitarian Aid Program, and will...als. ,, "This donation will directly support bu...
(Date:12/2/2009)...ENA, Calif.Researchers from the California Institu...in detail, and for the first time, the previously ...in called ubiquitin are added by enzymes called ub...cycle. Ubiquitin chains tag target proteins for de...ll. , "We found that ubiquitin ligases build ubi...
(Date:12/2/2009)... National Pen ( www.pens.com ), a ...nnounced today it is giving away 10,000 free busin...December 2, 2009 -- National Pen ( www.pens.com ),... announced today it is giving away 10,000 free bus...y to promote business that no other company in the...
Breaking Medicine News(10 mins):Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:National Pen Giving Away 10,000 Business Card Pens 2
...stries,Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, ...o Barrie Levitt, M.D., Chairman of Taro Pharmaceut...garding Taro,s purported,termination of the May 18...our agreement. We remain,skeptical of Taro,s turna...
... can read and have good phonetic skills - the abil...s may still be poor spellers. In a paper publishe...ton and Marian Annett, at the School of Psychology...rried out in a cohort of children drawn from norma...
...ry Health, CROMWELL, Conn., May 29 Though many d...ions (UTIs) are the second most common type,of inf...llion doctor visits,each year. One-third of women ...ze the signs of a UTI in the first place.,In respo...
...es as Many Calories as,Hand-Held, INDIANAPOLIS, M..., are quickly becoming the most coveted gaming,sys...ese systems appear to,be helpful in encouraging yo...he studies presented today examined energy expendi...
...rove in 83% of Patients S...FirstCall/ - Novadaq(R) Technologies Inc.,(TSX: ND...mage guidance,systems for the operating room, toda...R) System in commercial practice at the,recent Eur...
... study to be presented at America...y 29 The Montana Center for Work,Physiology and E...uman,clinical study at the Annual Meeting of the A...), had far fewer -- 23,percent -- upper respirator...
Other Medicine News:Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 2Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 3Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 4Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 5Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 6Health News:Sun Pharma Responds to Taro's Purported Termination of Merger Agreement 7Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Kids' Energy Expenditure High in Active Video Games 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 2Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 3Health News:Novadaq Updates on OPTTX Data Reported at Euroretina 4Health News:Montana Center for Work Physiology and Exercise Metabolism Presents Firefighter Health Study 2
(Date:12/2/2009)...sreal, December 2 Cardio...g developer of advanced,cardiovascular surgery tec...of Directors approved a one-for-three forward stoc...to Cardio Vascular Medical Device shareholders. ,...he estimated date the stock,split will be payable ...
(Date:12/2/2009)...., Dec. 2 Roche (SIX: RO...ed States Food & Drug Administration (FDA) app...nucleic acid test, to screen source plasma in pool...test, called the cobas® TaqScreen MPX Test fo...e, in-vitro test for the simultaneous, direct dete...
(Date:12/2/2009)...VER, N.J., Dec. 2 Novartis announc...presentation on Tasigna® (nilotinib) 200 mg c...onstrate the strength of the company,s hematology ..., The new data, at the 51st American Society of He...light the company,s current therapies and investig...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Advance in bowel cancer test research 48298 1Discovery raises new doubts about dinosaur bird links 8763 1Discovery raises new doubts about dinosaur bird links 8763 2Discovery raises new doubts about dinosaur bird links 8763 3Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 1Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 2Morphotek 28R 29 Inc Announces FDA Acceptance of Investigational New Drug Application for MORAb 004 a Monoclonal Antibody for the Treatment of Soli 48291 3
... WIRE)--Apr 23, 2007 - Aeolus,Pharmaceuticals, Inc...by researchers at Loma Linda University Medical Ce...hyrin antioxidants, AEOL,10113, may play an import...y ionizing radiation., Radiation therapy is used a...py in the care and management of nearly all adult ...
...eight loss medication Xenical,(orlistat 120mg) sig...lar risk factors such as blood pressure, glycaemic... people with type,2 diabetes and hypertension, acc...an Congress on Obesity (ECO), Budapest,Hungary.(1...already established,for Xenical that demonstrates ...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Wire Driver, Cannulated
Micro Saggital Saw
SmartDriver
Large Power Battery/Electric Reciprocating Saw
Medicine Products: